1. Molecular imaging biomarkers for immune checkpoint inhibitor therapy

   van de Donk, P. P., de Ruijter, L. K., Lub-de Hooge, M. N., Brouwers, A. H., van der Wekken, A. J., Oosting, S. F., Fehrmann, R. S. N., de Groot, D. J. A. & de Vries, E. G. E., 2020, In : Theranostics. 10, 4, p. 1708-1718 11 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma

   Verhoeff, S., van Es, S. C., Boon, E., van Helden, E., Angus, L., Elias, S. G., Oosting, S. F., Aarntzen, E. H., Brouwers, A. H., Kwee, T. C., Heskamp, S., Hoekstra, O. S., Verheul, H., Zwezerijnen, G. J. C., van Oordt, C. M. D. H., van der Veldt, A. A. M., de Vries, E. G. E., Boerman, O. C., van der Graaf, W. T. A., Oyen, W. J. G. & van Herpen, C. M. L., Oct-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, SUPPL 1, p. S67 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. [Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

   van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S. & van Oordt, C. W. M. D. H., 9-Nov-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Interobserver reproducibility of tumor uptake quantification with Zr-89-immuno-PET: a multicenter analysis

   Jauw, Y. W. S., Bensch, F., Brouwers, A. H., Hoekstra, O. S., Zijlstra, J. M., Pieplenbosch, S., Schroder, C. P., Zweegman, S., van Dongen, G. A. M. S., van Oordt, C. W. M. D. H., de Vries, E. G. E., de Vet, H. C. W., Boellaard, R. & Huisman, M. C., Aug-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, 9, p. 1840-1849 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT

   de Hosson, L. D., van der Loo-van der Schaaf, A. M., Boellaard, R., van Snick, J. H., de Vries, E. G. E., Brouwers, A. H. & Walenkamp, A. M. E., Aug-2019, In : Clinical Nuclear Medicine. 44, 8, p. 612-619 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (130) »